Farther Finance Advisors »

Enliven Therapeutics shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $82 6 13.83

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Apple Stock (AAPL)
Uva Unconstrained Medium-term Fixed Income Etf Etf (FFIU)
Vanguard Short-term Bond Etf Etf (BSV)
Nvidia Corporation Stock (NVDA)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Microsoft Corp Stock (MSFT)
Vanguard Intermediate-term Bond Etf Etf (BIV)
Ishares Core Msci Eafe Etf Etf (IEFA)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Ishares Core S&p Small Cap Etf Etf (IJR)
Ishares National Muni Bond Etf Etf (MUB)
Ishares Msci Eafe Value Etf Etf (EFV)
Spdr Nuveen Bloomberg Short Term Municipal Bond Etf Etf (SHM)

View all positions for Farther Finance Advisors

Top funds holding Enliven Therapeutics

OrbiMed Advisors
5AM Venture Management
VR Adviser
Commodore Capital
Citadel Advisors
Fairmount Funds Management
RA Capital Management
Vanguard Group
Boxer Capital
Henderson Group
Logos Global Management
Charles Schwab Investment Management
Bank of New York Mellon
BML Capital Management
Barclays

View all funds holding Enliven Therapeutics